Volumen | 186.277 |
|
|||||
News | - | ||||||
Tageshoch | 2,22 | Niedrig Hoch |
|||||
Tagestief | 2,08 |
Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Oramed Pharmaceuticals Inc | ORMP | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
2,19 | 2,08 | 2,22 | 2,10 | 2,18 |
Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
---|---|---|---|---|---|
769 | 186.277 | US$ 2,13 | US$ 396.384 | - | 1,67 - 4,16 |
Letzte Trade | Typ | Menge | Kurs | Währung |
---|---|---|---|---|
01:10:59 | 1 | US$ 2,20 | USD |
Finanzwerte ORMP
Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
---|---|---|---|---|---|---|
85,09M | 40,52M | - | 1,63M | 5,53M | 0,14 | 15,40 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Oramed Pharmaceuticals
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
09.5.2024 | 23:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
06.5.2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
19.3.2024 | 14:00 | GlobeNewswire Inc. | Scilex Holding Company Announces Repayment in Full of the.. |
06.3.2024 | 23:00 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
20.2.2024 | 14:42 | Edgar (US Regulatory) | Form 8-K - Current report |
20.2.2024 | 14:30 | PR Newswire (US) | Oramed Letter to Shareholders |
30.1.2024 | 23:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
23.1.2024 | 22:45 | Edgar (US Regulatory) | Form 8-K - Current report |
19.1.2024 | 22:45 | Edgar (US Regulatory) | Form 8-K - Current report |
08.1.2024 | 22:43 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
08.1.2024 | 22:41 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
08.1.2024 | 22:40 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
Forum Oramed Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
ORMP Historisch
Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
---|---|---|---|---|---|---|---|
1 Woche | 2,24 | 2,332 | 2,08 | 2,19 | 137.357 | -0,14 | -6,25% |
1 Monat | 2,37 | 2,49 | 2,08 | 2,27 | 107.229 | -0,27 | -11,39% |
3 Monate | 2,69 | 3,14 | 2,08 | 2,48 | 104.464 | -0,59 | -21,93% |
6 Monate | 2,20 | 3,67 | 2,08 | 2,64 | 154.347 | -0,10 | -4,55% |
1 Jahr | 4,00 | 4,16 | 1,67 | 2,82 | 187.749 | -1,90 | -47,50% |
3 Jahre | 12,08 | 31,54 | 1,67 | 8,41 | 687.633 | -9,98 | -82,62% |
5 Jahre | 3,28 | 31,54 | 1,67 | 8,02 | 525.216 | -1,18 | -35,98% |